Global Huntington Disease Medications Market Growth 2026-2032
The global Huntington Disease Medications market size is predicted to grow from US$ 3988 million in 2025 to US$ 11190 million in 2032; it is expected to grow at a CAGR of 16.2% from 2026 to 2032.
Huntington disease medications are primarily aimed at managing symptoms of this progressive neurodegenerative disorder, as there is currently no cure. Huntington disease affects movement, cognition, and behavior, and medications target these areas to improve patients’ quality of life. Key drugs include tetrabenazine and deutetrabenazine, which reduce involuntary movements (chorea) by decreasing dopamine in the brain.
United States market for Huntington Disease Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Huntington Disease Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Huntington Disease Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Huntington Disease Medications players cover Bausch Health, Teva, Neurocrine Biosciences, Hetero, Apotex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Huntington Disease Medications Industry Forecast” looks at past sales and reviews total world Huntington Disease Medications sales in 2025, providing a comprehensive analysis by region and market sector of projected Huntington Disease Medications sales for 2026 through 2032. With Huntington Disease Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Huntington Disease Medications industry.
This Insight Report provides a comprehensive analysis of the global Huntington Disease Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Huntington Disease Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Huntington Disease Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Huntington Disease Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Huntington Disease Medications.
This report presents a comprehensive overview, market shares, and growth opportunities of Huntington Disease Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Huntington Disease Medications market?
What factors are driving Huntington Disease Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Huntington Disease Medications market opportunities vary by end market size?
How does Huntington Disease Medications break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Huntington disease medications are primarily aimed at managing symptoms of this progressive neurodegenerative disorder, as there is currently no cure. Huntington disease affects movement, cognition, and behavior, and medications target these areas to improve patients’ quality of life. Key drugs include tetrabenazine and deutetrabenazine, which reduce involuntary movements (chorea) by decreasing dopamine in the brain.
United States market for Huntington Disease Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Huntington Disease Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Huntington Disease Medications is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Huntington Disease Medications players cover Bausch Health, Teva, Neurocrine Biosciences, Hetero, Apotex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Huntington Disease Medications Industry Forecast” looks at past sales and reviews total world Huntington Disease Medications sales in 2025, providing a comprehensive analysis by region and market sector of projected Huntington Disease Medications sales for 2026 through 2032. With Huntington Disease Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Huntington Disease Medications industry.
This Insight Report provides a comprehensive analysis of the global Huntington Disease Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Huntington Disease Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Huntington Disease Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Huntington Disease Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Huntington Disease Medications.
This report presents a comprehensive overview, market shares, and growth opportunities of Huntington Disease Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Valbenazine
- Deutetrabenazine
- Tetrabenazine
- Others
- Hospital and Clinic
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bausch Health
- Teva
- Neurocrine Biosciences
- Hetero
- Apotex
- Actavis Laboratories
- Mylan
- Bionpharma
- Dr. Reddy's Laboratories
- Chartwell Pharmaceuticals
- Sandoz
- Sun Pharmaceutical
- Lupin
- Zydus
What is the 10-year outlook for the global Huntington Disease Medications market?
What factors are driving Huntington Disease Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Huntington Disease Medications market opportunities vary by end market size?
How does Huntington Disease Medications break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Huntington Disease Medications Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Huntington Disease Medications by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Huntington Disease Medications by Country/Region, 2021, 2025 & 2032
2.2 Huntington Disease Medications Segment by Type
2.2.1 Valbenazine
2.2.2 Deutetrabenazine
2.2.3 Tetrabenazine
2.2.4 Others
2.2.5 Huntington Disease Medications Sales by Type
2.2.5.1 Global Huntington Disease Medications Sales Market Share by Type (2021-2026)
2.2.5.2 Global Huntington Disease Medications Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Huntington Disease Medications Sale Price by Type (2021-2026)
2.3 Huntington Disease Medications Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Huntington Disease Medications Sales by Application
2.3.4.1 Global Huntington Disease Medications Sale Market Share by Application (2021-2026)
2.3.4.2 Global Huntington Disease Medications Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Huntington Disease Medications Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Huntington Disease Medications Breakdown Data by Company
3.1.1 Global Huntington Disease Medications Annual Sales by Company (2021-2026)
3.1.2 Global Huntington Disease Medications Sales Market Share by Company (2021-2026)
3.2 Global Huntington Disease Medications Annual Revenue by Company (2021-2026)
3.2.1 Global Huntington Disease Medications Revenue by Company (2021-2026)
3.2.2 Global Huntington Disease Medications Revenue Market Share by Company (2021-2026)
3.3 Global Huntington Disease Medications Sale Price by Company
3.4 Key Manufacturers Huntington Disease Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Huntington Disease Medications Product Location Distribution
3.4.2 Players Huntington Disease Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUNTINGTON DISEASE MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Huntington Disease Medications Market Size by Geographic Region (2021-2026)
4.1.1 Global Huntington Disease Medications Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Huntington Disease Medications Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Huntington Disease Medications Market Size by Country/Region (2021-2026)
4.2.1 Global Huntington Disease Medications Annual Sales by Country/Region (2021-2026)
4.2.2 Global Huntington Disease Medications Annual Revenue by Country/Region (2021-2026)
4.3 Americas Huntington Disease Medications Sales Growth
4.4 APAC Huntington Disease Medications Sales Growth
4.5 Europe Huntington Disease Medications Sales Growth
4.6 Middle East & Africa Huntington Disease Medications Sales Growth
5 AMERICAS
5.1 Americas Huntington Disease Medications Sales by Country
5.1.1 Americas Huntington Disease Medications Sales by Country (2021-2026)
5.1.2 Americas Huntington Disease Medications Revenue by Country (2021-2026)
5.2 Americas Huntington Disease Medications Sales by Type (2021-2026)
5.3 Americas Huntington Disease Medications Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Huntington Disease Medications Sales by Region
6.1.1 APAC Huntington Disease Medications Sales by Region (2021-2026)
6.1.2 APAC Huntington Disease Medications Revenue by Region (2021-2026)
6.2 APAC Huntington Disease Medications Sales by Type (2021-2026)
6.3 APAC Huntington Disease Medications Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Huntington Disease Medications by Country
7.1.1 Europe Huntington Disease Medications Sales by Country (2021-2026)
7.1.2 Europe Huntington Disease Medications Revenue by Country (2021-2026)
7.2 Europe Huntington Disease Medications Sales by Type (2021-2026)
7.3 Europe Huntington Disease Medications Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Huntington Disease Medications by Country
8.1.1 Middle East & Africa Huntington Disease Medications Sales by Country (2021-2026)
8.1.2 Middle East & Africa Huntington Disease Medications Revenue by Country (2021-2026)
8.2 Middle East & Africa Huntington Disease Medications Sales by Type (2021-2026)
8.3 Middle East & Africa Huntington Disease Medications Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Huntington Disease Medications
10.3 Manufacturing Process Analysis of Huntington Disease Medications
10.4 Industry Chain Structure of Huntington Disease Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Huntington Disease Medications Distributors
11.3 Huntington Disease Medications Customer
12 WORLD FORECAST REVIEW FOR HUNTINGTON DISEASE MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Huntington Disease Medications Market Size Forecast by Region
12.1.1 Global Huntington Disease Medications Forecast by Region (2027-2032)
12.1.2 Global Huntington Disease Medications Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Huntington Disease Medications Forecast by Type (2027-2032)
12.7 Global Huntington Disease Medications Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bausch Health
13.1.1 Bausch Health Company Information
13.1.2 Bausch Health Huntington Disease Medications Product Portfolios and Specifications
13.1.3 Bausch Health Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bausch Health Main Business Overview
13.1.5 Bausch Health Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Huntington Disease Medications Product Portfolios and Specifications
13.2.3 Teva Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Neurocrine Biosciences
13.3.1 Neurocrine Biosciences Company Information
13.3.2 Neurocrine Biosciences Huntington Disease Medications Product Portfolios and Specifications
13.3.3 Neurocrine Biosciences Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Neurocrine Biosciences Main Business Overview
13.3.5 Neurocrine Biosciences Latest Developments
13.4 Hetero
13.4.1 Hetero Company Information
13.4.2 Hetero Huntington Disease Medications Product Portfolios and Specifications
13.4.3 Hetero Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hetero Main Business Overview
13.4.5 Hetero Latest Developments
13.5 Apotex
13.5.1 Apotex Company Information
13.5.2 Apotex Huntington Disease Medications Product Portfolios and Specifications
13.5.3 Apotex Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apotex Main Business Overview
13.5.5 Apotex Latest Developments
13.6 Actavis Laboratories
13.6.1 Actavis Laboratories Company Information
13.6.2 Actavis Laboratories Huntington Disease Medications Product Portfolios and Specifications
13.6.3 Actavis Laboratories Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Actavis Laboratories Main Business Overview
13.6.5 Actavis Laboratories Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Huntington Disease Medications Product Portfolios and Specifications
13.7.3 Mylan Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 Bionpharma
13.8.1 Bionpharma Company Information
13.8.2 Bionpharma Huntington Disease Medications Product Portfolios and Specifications
13.8.3 Bionpharma Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bionpharma Main Business Overview
13.8.5 Bionpharma Latest Developments
13.9 Dr. Reddy's Laboratories
13.9.1 Dr. Reddy's Laboratories Company Information
13.9.2 Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolios and Specifications
13.9.3 Dr. Reddy's Laboratories Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dr. Reddy's Laboratories Main Business Overview
13.9.5 Dr. Reddy's Laboratories Latest Developments
13.10 Chartwell Pharmaceuticals
13.10.1 Chartwell Pharmaceuticals Company Information
13.10.2 Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolios and Specifications
13.10.3 Chartwell Pharmaceuticals Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Chartwell Pharmaceuticals Main Business Overview
13.10.5 Chartwell Pharmaceuticals Latest Developments
13.11 Sandoz
13.11.1 Sandoz Company Information
13.11.2 Sandoz Huntington Disease Medications Product Portfolios and Specifications
13.11.3 Sandoz Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sandoz Main Business Overview
13.11.5 Sandoz Latest Developments
13.12 Sun Pharmaceutical
13.12.1 Sun Pharmaceutical Company Information
13.12.2 Sun Pharmaceutical Huntington Disease Medications Product Portfolios and Specifications
13.12.3 Sun Pharmaceutical Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sun Pharmaceutical Main Business Overview
13.12.5 Sun Pharmaceutical Latest Developments
13.13 Lupin
13.13.1 Lupin Company Information
13.13.2 Lupin Huntington Disease Medications Product Portfolios and Specifications
13.13.3 Lupin Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Lupin Main Business Overview
13.13.5 Lupin Latest Developments
13.14 Zydus
13.14.1 Zydus Company Information
13.14.2 Zydus Huntington Disease Medications Product Portfolios and Specifications
13.14.3 Zydus Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Zydus Main Business Overview
13.14.5 Zydus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Huntington Disease Medications Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Huntington Disease Medications by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Huntington Disease Medications by Country/Region, 2021, 2025 & 2032
2.2 Huntington Disease Medications Segment by Type
2.2.1 Valbenazine
2.2.2 Deutetrabenazine
2.2.3 Tetrabenazine
2.2.4 Others
2.2.5 Huntington Disease Medications Sales by Type
2.2.5.1 Global Huntington Disease Medications Sales Market Share by Type (2021-2026)
2.2.5.2 Global Huntington Disease Medications Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Huntington Disease Medications Sale Price by Type (2021-2026)
2.3 Huntington Disease Medications Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Huntington Disease Medications Sales by Application
2.3.4.1 Global Huntington Disease Medications Sale Market Share by Application (2021-2026)
2.3.4.2 Global Huntington Disease Medications Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Huntington Disease Medications Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Huntington Disease Medications Breakdown Data by Company
3.1.1 Global Huntington Disease Medications Annual Sales by Company (2021-2026)
3.1.2 Global Huntington Disease Medications Sales Market Share by Company (2021-2026)
3.2 Global Huntington Disease Medications Annual Revenue by Company (2021-2026)
3.2.1 Global Huntington Disease Medications Revenue by Company (2021-2026)
3.2.2 Global Huntington Disease Medications Revenue Market Share by Company (2021-2026)
3.3 Global Huntington Disease Medications Sale Price by Company
3.4 Key Manufacturers Huntington Disease Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Huntington Disease Medications Product Location Distribution
3.4.2 Players Huntington Disease Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUNTINGTON DISEASE MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Huntington Disease Medications Market Size by Geographic Region (2021-2026)
4.1.1 Global Huntington Disease Medications Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Huntington Disease Medications Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Huntington Disease Medications Market Size by Country/Region (2021-2026)
4.2.1 Global Huntington Disease Medications Annual Sales by Country/Region (2021-2026)
4.2.2 Global Huntington Disease Medications Annual Revenue by Country/Region (2021-2026)
4.3 Americas Huntington Disease Medications Sales Growth
4.4 APAC Huntington Disease Medications Sales Growth
4.5 Europe Huntington Disease Medications Sales Growth
4.6 Middle East & Africa Huntington Disease Medications Sales Growth
5 AMERICAS
5.1 Americas Huntington Disease Medications Sales by Country
5.1.1 Americas Huntington Disease Medications Sales by Country (2021-2026)
5.1.2 Americas Huntington Disease Medications Revenue by Country (2021-2026)
5.2 Americas Huntington Disease Medications Sales by Type (2021-2026)
5.3 Americas Huntington Disease Medications Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Huntington Disease Medications Sales by Region
6.1.1 APAC Huntington Disease Medications Sales by Region (2021-2026)
6.1.2 APAC Huntington Disease Medications Revenue by Region (2021-2026)
6.2 APAC Huntington Disease Medications Sales by Type (2021-2026)
6.3 APAC Huntington Disease Medications Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Huntington Disease Medications by Country
7.1.1 Europe Huntington Disease Medications Sales by Country (2021-2026)
7.1.2 Europe Huntington Disease Medications Revenue by Country (2021-2026)
7.2 Europe Huntington Disease Medications Sales by Type (2021-2026)
7.3 Europe Huntington Disease Medications Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Huntington Disease Medications by Country
8.1.1 Middle East & Africa Huntington Disease Medications Sales by Country (2021-2026)
8.1.2 Middle East & Africa Huntington Disease Medications Revenue by Country (2021-2026)
8.2 Middle East & Africa Huntington Disease Medications Sales by Type (2021-2026)
8.3 Middle East & Africa Huntington Disease Medications Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Huntington Disease Medications
10.3 Manufacturing Process Analysis of Huntington Disease Medications
10.4 Industry Chain Structure of Huntington Disease Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Huntington Disease Medications Distributors
11.3 Huntington Disease Medications Customer
12 WORLD FORECAST REVIEW FOR HUNTINGTON DISEASE MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Huntington Disease Medications Market Size Forecast by Region
12.1.1 Global Huntington Disease Medications Forecast by Region (2027-2032)
12.1.2 Global Huntington Disease Medications Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Huntington Disease Medications Forecast by Type (2027-2032)
12.7 Global Huntington Disease Medications Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bausch Health
13.1.1 Bausch Health Company Information
13.1.2 Bausch Health Huntington Disease Medications Product Portfolios and Specifications
13.1.3 Bausch Health Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bausch Health Main Business Overview
13.1.5 Bausch Health Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Huntington Disease Medications Product Portfolios and Specifications
13.2.3 Teva Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Neurocrine Biosciences
13.3.1 Neurocrine Biosciences Company Information
13.3.2 Neurocrine Biosciences Huntington Disease Medications Product Portfolios and Specifications
13.3.3 Neurocrine Biosciences Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Neurocrine Biosciences Main Business Overview
13.3.5 Neurocrine Biosciences Latest Developments
13.4 Hetero
13.4.1 Hetero Company Information
13.4.2 Hetero Huntington Disease Medications Product Portfolios and Specifications
13.4.3 Hetero Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hetero Main Business Overview
13.4.5 Hetero Latest Developments
13.5 Apotex
13.5.1 Apotex Company Information
13.5.2 Apotex Huntington Disease Medications Product Portfolios and Specifications
13.5.3 Apotex Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apotex Main Business Overview
13.5.5 Apotex Latest Developments
13.6 Actavis Laboratories
13.6.1 Actavis Laboratories Company Information
13.6.2 Actavis Laboratories Huntington Disease Medications Product Portfolios and Specifications
13.6.3 Actavis Laboratories Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Actavis Laboratories Main Business Overview
13.6.5 Actavis Laboratories Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Huntington Disease Medications Product Portfolios and Specifications
13.7.3 Mylan Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 Bionpharma
13.8.1 Bionpharma Company Information
13.8.2 Bionpharma Huntington Disease Medications Product Portfolios and Specifications
13.8.3 Bionpharma Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bionpharma Main Business Overview
13.8.5 Bionpharma Latest Developments
13.9 Dr. Reddy's Laboratories
13.9.1 Dr. Reddy's Laboratories Company Information
13.9.2 Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolios and Specifications
13.9.3 Dr. Reddy's Laboratories Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dr. Reddy's Laboratories Main Business Overview
13.9.5 Dr. Reddy's Laboratories Latest Developments
13.10 Chartwell Pharmaceuticals
13.10.1 Chartwell Pharmaceuticals Company Information
13.10.2 Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolios and Specifications
13.10.3 Chartwell Pharmaceuticals Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Chartwell Pharmaceuticals Main Business Overview
13.10.5 Chartwell Pharmaceuticals Latest Developments
13.11 Sandoz
13.11.1 Sandoz Company Information
13.11.2 Sandoz Huntington Disease Medications Product Portfolios and Specifications
13.11.3 Sandoz Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sandoz Main Business Overview
13.11.5 Sandoz Latest Developments
13.12 Sun Pharmaceutical
13.12.1 Sun Pharmaceutical Company Information
13.12.2 Sun Pharmaceutical Huntington Disease Medications Product Portfolios and Specifications
13.12.3 Sun Pharmaceutical Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sun Pharmaceutical Main Business Overview
13.12.5 Sun Pharmaceutical Latest Developments
13.13 Lupin
13.13.1 Lupin Company Information
13.13.2 Lupin Huntington Disease Medications Product Portfolios and Specifications
13.13.3 Lupin Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Lupin Main Business Overview
13.13.5 Lupin Latest Developments
13.14 Zydus
13.14.1 Zydus Company Information
13.14.2 Zydus Huntington Disease Medications Product Portfolios and Specifications
13.14.3 Zydus Huntington Disease Medications Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Zydus Main Business Overview
13.14.5 Zydus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Huntington Disease Medications Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Huntington Disease Medications Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Valbenazine
Table 4. Major Players of Deutetrabenazine
Table 5. Major Players of Tetrabenazine
Table 6. Major Players of Others
Table 7. Global Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 8. Global Huntington Disease Medications Sales Market Share by Type (2021-2026)
Table 9. Global Huntington Disease Medications Revenue by Type (2021-2026) & ($ million)
Table 10. Global Huntington Disease Medications Revenue Market Share by Type (2021-2026)
Table 11. Global Huntington Disease Medications Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Huntington Disease Medications Sale by Application (2021-2026) & (K Units)
Table 13. Global Huntington Disease Medications Sale Market Share by Application (2021-2026)
Table 14. Global Huntington Disease Medications Revenue by Application (2021-2026) & ($ million)
Table 15. Global Huntington Disease Medications Revenue Market Share by Application (2021-2026)
Table 16. Global Huntington Disease Medications Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Huntington Disease Medications Sales by Company (2021-2026) & (K Units)
Table 18. Global Huntington Disease Medications Sales Market Share by Company (2021-2026)
Table 19. Global Huntington Disease Medications Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Huntington Disease Medications Revenue Market Share by Company (2021-2026)
Table 21. Global Huntington Disease Medications Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Huntington Disease Medications Producing Area Distribution and Sales Area
Table 23. Players Huntington Disease Medications Products Offered
Table 24. Huntington Disease Medications Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Huntington Disease Medications Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Huntington Disease Medications Sales Market Share Geographic Region (2021-2026)
Table 29. Global Huntington Disease Medications Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Huntington Disease Medications Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Huntington Disease Medications Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Huntington Disease Medications Sales Market Share by Country/Region (2021-2026)
Table 33. Global Huntington Disease Medications Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Huntington Disease Medications Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Huntington Disease Medications Sales by Country (2021-2026) & (K Units)
Table 36. Americas Huntington Disease Medications Sales Market Share by Country (2021-2026)
Table 37. Americas Huntington Disease Medications Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 39. Americas Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 40. APAC Huntington Disease Medications Sales by Region (2021-2026) & (K Units)
Table 41. APAC Huntington Disease Medications Sales Market Share by Region (2021-2026)
Table 42. APAC Huntington Disease Medications Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 44. APAC Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 45. Europe Huntington Disease Medications Sales by Country (2021-2026) & (K Units)
Table 46. Europe Huntington Disease Medications Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 48. Europe Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Huntington Disease Medications Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Huntington Disease Medications Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Huntington Disease Medications
Table 54. Key Market Challenges & Risks of Huntington Disease Medications
Table 55. Key Industry Trends of Huntington Disease Medications
Table 56. Huntington Disease Medications Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Huntington Disease Medications Distributors List
Table 59. Huntington Disease Medications Customer List
Table 60. Global Huntington Disease Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Huntington Disease Medications Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Huntington Disease Medications Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Huntington Disease Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Huntington Disease Medications Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Huntington Disease Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Huntington Disease Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Huntington Disease Medications Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Huntington Disease Medications Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Huntington Disease Medications Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Huntington Disease Medications Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Bausch Health Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 75. Bausch Health Huntington Disease Medications Product Portfolios and Specifications
Table 76. Bausch Health Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Bausch Health Main Business
Table 78. Bausch Health Latest Developments
Table 79. Teva Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Huntington Disease Medications Product Portfolios and Specifications
Table 81. Teva Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Neurocrine Biosciences Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 85. Neurocrine Biosciences Huntington Disease Medications Product Portfolios and Specifications
Table 86. Neurocrine Biosciences Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Neurocrine Biosciences Main Business
Table 88. Neurocrine Biosciences Latest Developments
Table 89. Hetero Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 90. Hetero Huntington Disease Medications Product Portfolios and Specifications
Table 91. Hetero Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Hetero Main Business
Table 93. Hetero Latest Developments
Table 94. Apotex Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 95. Apotex Huntington Disease Medications Product Portfolios and Specifications
Table 96. Apotex Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Apotex Main Business
Table 98. Apotex Latest Developments
Table 99. Actavis Laboratories Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 100. Actavis Laboratories Huntington Disease Medications Product Portfolios and Specifications
Table 101. Actavis Laboratories Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Actavis Laboratories Main Business
Table 103. Actavis Laboratories Latest Developments
Table 104. Mylan Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 105. Mylan Huntington Disease Medications Product Portfolios and Specifications
Table 106. Mylan Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Mylan Main Business
Table 108. Mylan Latest Developments
Table 109. Bionpharma Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 110. Bionpharma Huntington Disease Medications Product Portfolios and Specifications
Table 111. Bionpharma Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bionpharma Main Business
Table 113. Bionpharma Latest Developments
Table 114. Dr. Reddy's Laboratories Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 115. Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolios and Specifications
Table 116. Dr. Reddy's Laboratories Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Dr. Reddy's Laboratories Main Business
Table 118. Dr. Reddy's Laboratories Latest Developments
Table 119. Chartwell Pharmaceuticals Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 120. Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolios and Specifications
Table 121. Chartwell Pharmaceuticals Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Chartwell Pharmaceuticals Main Business
Table 123. Chartwell Pharmaceuticals Latest Developments
Table 124. Sandoz Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 125. Sandoz Huntington Disease Medications Product Portfolios and Specifications
Table 126. Sandoz Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Sandoz Main Business
Table 128. Sandoz Latest Developments
Table 129. Sun Pharmaceutical Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 130. Sun Pharmaceutical Huntington Disease Medications Product Portfolios and Specifications
Table 131. Sun Pharmaceutical Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Sun Pharmaceutical Main Business
Table 133. Sun Pharmaceutical Latest Developments
Table 134. Lupin Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 135. Lupin Huntington Disease Medications Product Portfolios and Specifications
Table 136. Lupin Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Lupin Main Business
Table 138. Lupin Latest Developments
Table 139. Zydus Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 140. Zydus Huntington Disease Medications Product Portfolios and Specifications
Table 141. Zydus Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Zydus Main Business
Table 143. Zydus Latest Developments
Table 1. Huntington Disease Medications Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Huntington Disease Medications Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Valbenazine
Table 4. Major Players of Deutetrabenazine
Table 5. Major Players of Tetrabenazine
Table 6. Major Players of Others
Table 7. Global Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 8. Global Huntington Disease Medications Sales Market Share by Type (2021-2026)
Table 9. Global Huntington Disease Medications Revenue by Type (2021-2026) & ($ million)
Table 10. Global Huntington Disease Medications Revenue Market Share by Type (2021-2026)
Table 11. Global Huntington Disease Medications Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Huntington Disease Medications Sale by Application (2021-2026) & (K Units)
Table 13. Global Huntington Disease Medications Sale Market Share by Application (2021-2026)
Table 14. Global Huntington Disease Medications Revenue by Application (2021-2026) & ($ million)
Table 15. Global Huntington Disease Medications Revenue Market Share by Application (2021-2026)
Table 16. Global Huntington Disease Medications Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Huntington Disease Medications Sales by Company (2021-2026) & (K Units)
Table 18. Global Huntington Disease Medications Sales Market Share by Company (2021-2026)
Table 19. Global Huntington Disease Medications Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Huntington Disease Medications Revenue Market Share by Company (2021-2026)
Table 21. Global Huntington Disease Medications Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Huntington Disease Medications Producing Area Distribution and Sales Area
Table 23. Players Huntington Disease Medications Products Offered
Table 24. Huntington Disease Medications Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Huntington Disease Medications Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Huntington Disease Medications Sales Market Share Geographic Region (2021-2026)
Table 29. Global Huntington Disease Medications Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Huntington Disease Medications Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Huntington Disease Medications Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Huntington Disease Medications Sales Market Share by Country/Region (2021-2026)
Table 33. Global Huntington Disease Medications Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Huntington Disease Medications Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Huntington Disease Medications Sales by Country (2021-2026) & (K Units)
Table 36. Americas Huntington Disease Medications Sales Market Share by Country (2021-2026)
Table 37. Americas Huntington Disease Medications Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 39. Americas Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 40. APAC Huntington Disease Medications Sales by Region (2021-2026) & (K Units)
Table 41. APAC Huntington Disease Medications Sales Market Share by Region (2021-2026)
Table 42. APAC Huntington Disease Medications Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 44. APAC Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 45. Europe Huntington Disease Medications Sales by Country (2021-2026) & (K Units)
Table 46. Europe Huntington Disease Medications Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 48. Europe Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Huntington Disease Medications Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Huntington Disease Medications Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Huntington Disease Medications Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Huntington Disease Medications Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Huntington Disease Medications
Table 54. Key Market Challenges & Risks of Huntington Disease Medications
Table 55. Key Industry Trends of Huntington Disease Medications
Table 56. Huntington Disease Medications Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Huntington Disease Medications Distributors List
Table 59. Huntington Disease Medications Customer List
Table 60. Global Huntington Disease Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Huntington Disease Medications Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Huntington Disease Medications Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Huntington Disease Medications Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Huntington Disease Medications Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Huntington Disease Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Huntington Disease Medications Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Huntington Disease Medications Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Huntington Disease Medications Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Huntington Disease Medications Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Huntington Disease Medications Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Bausch Health Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 75. Bausch Health Huntington Disease Medications Product Portfolios and Specifications
Table 76. Bausch Health Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Bausch Health Main Business
Table 78. Bausch Health Latest Developments
Table 79. Teva Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Huntington Disease Medications Product Portfolios and Specifications
Table 81. Teva Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Neurocrine Biosciences Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 85. Neurocrine Biosciences Huntington Disease Medications Product Portfolios and Specifications
Table 86. Neurocrine Biosciences Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Neurocrine Biosciences Main Business
Table 88. Neurocrine Biosciences Latest Developments
Table 89. Hetero Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 90. Hetero Huntington Disease Medications Product Portfolios and Specifications
Table 91. Hetero Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Hetero Main Business
Table 93. Hetero Latest Developments
Table 94. Apotex Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 95. Apotex Huntington Disease Medications Product Portfolios and Specifications
Table 96. Apotex Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Apotex Main Business
Table 98. Apotex Latest Developments
Table 99. Actavis Laboratories Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 100. Actavis Laboratories Huntington Disease Medications Product Portfolios and Specifications
Table 101. Actavis Laboratories Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Actavis Laboratories Main Business
Table 103. Actavis Laboratories Latest Developments
Table 104. Mylan Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 105. Mylan Huntington Disease Medications Product Portfolios and Specifications
Table 106. Mylan Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Mylan Main Business
Table 108. Mylan Latest Developments
Table 109. Bionpharma Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 110. Bionpharma Huntington Disease Medications Product Portfolios and Specifications
Table 111. Bionpharma Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bionpharma Main Business
Table 113. Bionpharma Latest Developments
Table 114. Dr. Reddy's Laboratories Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 115. Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolios and Specifications
Table 116. Dr. Reddy's Laboratories Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Dr. Reddy's Laboratories Main Business
Table 118. Dr. Reddy's Laboratories Latest Developments
Table 119. Chartwell Pharmaceuticals Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 120. Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolios and Specifications
Table 121. Chartwell Pharmaceuticals Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Chartwell Pharmaceuticals Main Business
Table 123. Chartwell Pharmaceuticals Latest Developments
Table 124. Sandoz Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 125. Sandoz Huntington Disease Medications Product Portfolios and Specifications
Table 126. Sandoz Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Sandoz Main Business
Table 128. Sandoz Latest Developments
Table 129. Sun Pharmaceutical Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 130. Sun Pharmaceutical Huntington Disease Medications Product Portfolios and Specifications
Table 131. Sun Pharmaceutical Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Sun Pharmaceutical Main Business
Table 133. Sun Pharmaceutical Latest Developments
Table 134. Lupin Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 135. Lupin Huntington Disease Medications Product Portfolios and Specifications
Table 136. Lupin Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Lupin Main Business
Table 138. Lupin Latest Developments
Table 139. Zydus Basic Information, Huntington Disease Medications Manufacturing Base, Sales Area and Its Competitors
Table 140. Zydus Huntington Disease Medications Product Portfolios and Specifications
Table 141. Zydus Huntington Disease Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Zydus Main Business
Table 143. Zydus Latest Developments
LIST OF FIGURES
Figure 1. Picture of Huntington Disease Medications
Figure 2. Huntington Disease Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Huntington Disease Medications Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Huntington Disease Medications Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Huntington Disease Medications Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Huntington Disease Medications Sales Market Share by Country/Region (2025)
Figure 10. Huntington Disease Medications Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Valbenazine
Figure 12. Product Picture of Deutetrabenazine
Figure 13. Product Picture of Tetrabenazine
Figure 14. Product Picture of Others
Figure 15. Global Huntington Disease Medications Sales Market Share by Type in 2026
Figure 16. Global Huntington Disease Medications Revenue Market Share by Type (2021-2026)
Figure 17. Huntington Disease Medications Consumed in Hospital and Clinic
Figure 18. Global Huntington Disease Medications Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 19. Huntington Disease Medications Consumed in Pharmacy
Figure 20. Global Huntington Disease Medications Market: Pharmacy (2021-2026) & (K Units)
Figure 21. Huntington Disease Medications Consumed in Other
Figure 22. Global Huntington Disease Medications Market: Other (2021-2026) & (K Units)
Figure 23. Global Huntington Disease Medications Sale Market Share by Application (2025)
Figure 24. Global Huntington Disease Medications Revenue Market Share by Application in 2026
Figure 25. Huntington Disease Medications Sales by Company in 2026 (K Units)
Figure 26. Global Huntington Disease Medications Sales Market Share by Company in 2026
Figure 27. Huntington Disease Medications Revenue by Company in 2026 ($ millions)
Figure 28. Global Huntington Disease Medications Revenue Market Share by Company in 2026
Figure 29. Global Huntington Disease Medications Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Huntington Disease Medications Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 32. Americas Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 33. APAC Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 34. APAC Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 35. Europe Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 36. Europe Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 39. Americas Huntington Disease Medications Sales Market Share by Country in 2026
Figure 40. Americas Huntington Disease Medications Revenue Market Share by Country (2021-2026)
Figure 41. Americas Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 42. Americas Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 43. United States Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Huntington Disease Medications Sales Market Share by Region in 2026
Figure 48. APAC Huntington Disease Medications Revenue Market Share by Region (2021-2026)
Figure 49. APAC Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 50. APAC Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 51. China Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 55. India Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Huntington Disease Medications Sales Market Share by Country in 2026
Figure 59. Europe Huntington Disease Medications Revenue Market Share by Country (2021-2026)
Figure 60. Europe Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 61. Europe Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 62. Germany Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 63. France Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Huntington Disease Medications Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 70. Egypt Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Huntington Disease Medications in 2026
Figure 76. Manufacturing Process Analysis of Huntington Disease Medications
Figure 77. Industry Chain Structure of Huntington Disease Medications
Figure 78. Channels of Distribution
Figure 79. Global Huntington Disease Medications Sales Market Forecast by Region (2027-2032)
Figure 80. Global Huntington Disease Medications Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Huntington Disease Medications Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Huntington Disease Medications Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Huntington Disease Medications Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Huntington Disease Medications Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Huntington Disease Medications
Figure 2. Huntington Disease Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Huntington Disease Medications Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Huntington Disease Medications Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Huntington Disease Medications Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Huntington Disease Medications Sales Market Share by Country/Region (2025)
Figure 10. Huntington Disease Medications Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Valbenazine
Figure 12. Product Picture of Deutetrabenazine
Figure 13. Product Picture of Tetrabenazine
Figure 14. Product Picture of Others
Figure 15. Global Huntington Disease Medications Sales Market Share by Type in 2026
Figure 16. Global Huntington Disease Medications Revenue Market Share by Type (2021-2026)
Figure 17. Huntington Disease Medications Consumed in Hospital and Clinic
Figure 18. Global Huntington Disease Medications Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 19. Huntington Disease Medications Consumed in Pharmacy
Figure 20. Global Huntington Disease Medications Market: Pharmacy (2021-2026) & (K Units)
Figure 21. Huntington Disease Medications Consumed in Other
Figure 22. Global Huntington Disease Medications Market: Other (2021-2026) & (K Units)
Figure 23. Global Huntington Disease Medications Sale Market Share by Application (2025)
Figure 24. Global Huntington Disease Medications Revenue Market Share by Application in 2026
Figure 25. Huntington Disease Medications Sales by Company in 2026 (K Units)
Figure 26. Global Huntington Disease Medications Sales Market Share by Company in 2026
Figure 27. Huntington Disease Medications Revenue by Company in 2026 ($ millions)
Figure 28. Global Huntington Disease Medications Revenue Market Share by Company in 2026
Figure 29. Global Huntington Disease Medications Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Huntington Disease Medications Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 32. Americas Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 33. APAC Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 34. APAC Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 35. Europe Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 36. Europe Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Huntington Disease Medications Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Huntington Disease Medications Revenue 2021-2026 ($ millions)
Figure 39. Americas Huntington Disease Medications Sales Market Share by Country in 2026
Figure 40. Americas Huntington Disease Medications Revenue Market Share by Country (2021-2026)
Figure 41. Americas Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 42. Americas Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 43. United States Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Huntington Disease Medications Sales Market Share by Region in 2026
Figure 48. APAC Huntington Disease Medications Revenue Market Share by Region (2021-2026)
Figure 49. APAC Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 50. APAC Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 51. China Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 55. India Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Huntington Disease Medications Sales Market Share by Country in 2026
Figure 59. Europe Huntington Disease Medications Revenue Market Share by Country (2021-2026)
Figure 60. Europe Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 61. Europe Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 62. Germany Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 63. France Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Huntington Disease Medications Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Huntington Disease Medications Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Huntington Disease Medications Sales Market Share by Application (2021-2026)
Figure 70. Egypt Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Huntington Disease Medications Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Huntington Disease Medications in 2026
Figure 76. Manufacturing Process Analysis of Huntington Disease Medications
Figure 77. Industry Chain Structure of Huntington Disease Medications
Figure 78. Channels of Distribution
Figure 79. Global Huntington Disease Medications Sales Market Forecast by Region (2027-2032)
Figure 80. Global Huntington Disease Medications Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Huntington Disease Medications Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Huntington Disease Medications Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Huntington Disease Medications Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Huntington Disease Medications Revenue Market Share Forecast by Application (2027-2032)
